3min chapter

Breakpoints cover image

#35 – Oral Beta-Lactams, Are We Serious?

Breakpoints

CHAPTER

The Implications of the OViva Study on Oral Antibiotics

General: I don't expect that either of these studies added to the existing literature has drastically shifted the management for most patients or providers. But it's not hard to come up with arguments why you would or wouldn't use one or the other in any one patient, he says. Zara: More time will be needed before PO data life comes really become sort of a comfortable treatment option.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode